Coloplast A/S (OTCMKTS:CLPBY) Announces Quarterly Earnings Results, Hits Estimates

Coloplast A/S (OTCMKTS:CLPBY) released its quarterly earnings data on Tuesday. The company reported $0.10 earnings per share for the quarter, hitting the consensus estimate of $0.10, Zacks reports. The business had revenue of $1.14 billion for the quarter, compared to analyst estimates of $1.12 billion. Coloplast A/S had a net margin of 7.46% and a return on equity of 33.15%.

Coloplast A/S Trading Up 3.2%

OTCMKTS:CLPBY opened at $6.79 on Wednesday. The company has a debt-to-equity ratio of 1.66, a current ratio of 1.75 and a quick ratio of 1.09. The business’s 50-day simple moving average is $6.24 and its 200-day simple moving average is $6.67. Coloplast A/S has a fifty-two week low of $5.64 and a fifty-two week high of $10.03. The stock has a market capitalization of $15.30 billion, a PE ratio of 48.50, a price-to-earnings-growth ratio of 2.12 and a beta of 0.13.

Analyst Ratings Changes

Separately, Kepler Capital Markets upgraded shares of Coloplast A/S to a “strong-buy” rating in a report on Wednesday, May 20th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold”.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.